HC Wainwright & Co. Reiterates Buy on Precigen, Maintains $6 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Precigen (NASDAQ:PGEN) and maintained a $6 price target, as stated by analyst Swayampakula Ramakanth.
June 03, 2024 | 4:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Precigen and maintained a $6 price target, indicating continued confidence in the company's prospects.
The reiteration of a Buy rating and maintenance of a $6 price target by a reputable analyst firm like HC Wainwright & Co. is likely to positively influence investor sentiment and potentially drive short-term price appreciation for PGEN.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100